Ligand Pharmaceuticals
LGND
#4131
Rank
$2.21 B
Marketcap
$117.17
Share price
5.03%
Change (1 day)
101.60%
Change (1 year)

EPS for Ligand Pharmaceuticals (LGND)

EPS in 2023 (TTM): $1.57

According to Ligand Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $1.57. In 2022 the company made an earnings per share (EPS) of -$1.98 a decrease over its 2021 EPS that were of $3.46.

EPS history for Ligand Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$1.57-179.29%
2022-$1.98-157.23%
2021$3.46-2571.43%
2020-$0.14-100.46%
2019$30.61353.48%
2018$6.751025%
2017$0.60-700%
2016-$0.10000-100.87%
2015$11.561859.32%
2014$0.595.36%
2013$0.568.0704505322479E+18%
2012$0.0000000000-100%
2011$0.49-194.23%
2010-$0.52548.38%
2009-$0.08020-98.7%
2008-$6.18-136.52%
2007$16.92-787.8%
2006-$2.46-14.58%
2005-$2.88-21.31%
2004-$3.66-55.15%
2003-$8.1681.33%
2002-$4.502.74%
2001-$4.38-45.93%
2000-$8.10-14.56%
1999-$9.48-45.52%
1998-$17.40-3.97%
1997-$18.12132.31%
1996-$7.80

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$14.15 801.27%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.36-122.93%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.50 122.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
$1.82 16.03%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.86 18.47%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.43 245.81%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.97 152.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.12 226.11%๐Ÿ‡บ๐Ÿ‡ธ USA
$14.09 797.15%๐Ÿ‡บ๐Ÿ‡ธ USA